Emily Leproust

Emily Leproust

Chief Executive Officer at TWIST BIOSCIENCE CORPORATION

Net worth: 58 M $ as of 31/05/2026

53 year
Finance
Health Technology
Consumer Services

Profile

Emily Marine Leproust founded Twist Bioscience Corp. and Petri. Dr. Leproust holds the position of Chairman, President & Chief Executive Officer for Twist Bioscience Corp. She is also on the board of CM Life Sciences, Inc. Dr. Leproust previously was Chairman at Nektar Therapeutics and Director-Applications & Chemistry at Agilent Technologies, Inc. Dr. Leproust received a doctorate from the University of Houston and a graduate degree from Lyon School of Industrial Chemistry.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
08/06/2026 844,607 ( 1.36% ) 56 M $ 31/05/2026
20/04/2026 26,326 ( 0.09% ) 1 M $ 31/05/2026

Emily Leproust active positions

CompaniesPositionStart
TWIST BIOSCIENCE CORPORATION Chief Executive Officer 01/01/2013
GENEDX HOLDINGS CORP. Director/Board Member 01/09/2020
Consultant / Advisor 01/02/2021
Private Equity Investor -
Director/Board Member 13/10/2023

Former positions of Emily Leproust

CompaniesPositionEnd
AGILENT TECHNOLOGIES, INC. Corporate Officer/Principal 01/04/2013
SEM4 HLDG Director/Board Member -
NEKTAR THERAPEUTICS Chairman -
Founder -
See the detail of Emily Leproust's experience

Training of Emily Leproust

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Finance

Finance

Consumer Services

Finance

Finance

Health Services

  1. Stock Market
  2. Insiders
  3. Emily Leproust
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!